InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,555.74
(
-0.16%
)
US TECH 100
19,095.20
(
-1.09%
)
Dow Jones
40,358.09
(
-0.14%
)
Brent Oil
80.49
(
-0.35%
)
Bitcoin
65,951.62
(
0.04%
)
Post# of 43124
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

cowtown jay

Send PM Follow Ignore
Followers 87
Posts 6759
Boards Moderated 1
Alias Born 09/18/2009

cowtown jay

Re: Knuckle Sandwich post# 31883

Saturday, 08/07/2021 12:34:30 AM

Saturday, August 07, 2021 12:34:30 AM

Post# of 43124
I'm not sure what to make of this, Knuckle.

Was the decision to stop recruiting for the risankizumab trial because of inferior performance compared to lenz? Or was recruitment stopped because risankizumab already has FDA approval and a BLA for the treatment of psoriasis? I suspect it's the former.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up